Correspondingly, the inhibitors of GSK-3 and HDAC have been reported to be effective in suppressing AD (Green et al., 2008; De Simone et al., 2019; Soares Romeiro et al., 2019). This evidence concerns the gene HDAC9 and Alzheimer disease.